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Background: In mammalian development, the formation of most tissues is achieved by a relatively small repertoire
of basic morphogenetic events (e.g. cell adhesion, locomotion, apoptosis, etc.), permutated in various sequences to
form different tissues. Together with cell differentiation, these mechanisms allow populations of cells to organize
themselves into defined geometries and structures, as simple embryos develop into complex organisms. The
control of tissue morphogenesis by populations of engineered cells is a potentially very powerful but neglected
aspect of synthetic biology.
Results: We have assembled a modular library of synthetic morphogenetic driver genes to control (separately)
mammalian cell adhesion, locomotion, fusion, proliferation and elective cell death. Here we describe this library
and demonstrate its use in the T-REx-293 human cell line to induce each of these desired morphological behaviours
on command.
Conclusions: Building on from the simple test systems described here, we want to extend engineered control of
morphogenetic cell behaviour to more complex 3D structures that can inform embryologists and may, in the
future, be used in surgery and regenerative medicine, making synthetic morphology a powerful tool for
developmental biology and tissue engineering.
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Human embryonic kidney cellsBackground
Most efforts in synthetic biology have so far concen-
trated on the engineering of metabolic pathways or the
engineering of sensory and logic systems, generally (al-
though not exclusively) in unicellular organisms [1-5].
Anatomical structure, a feature as essential to complex
animals as metabolism and logic, has so far received very
little attention. However, the recent report by Carvalho
et al. [6], who generated morphogen diffusion gradients
from engineered cysts, illustrates the power of synthetic
tools towards spatial engineering in mammalian cells. In
recent essays, we have proposed the construction of gen-
etic modules for ‘synthetic morphology’: programming
mammalian cells to display specific morphogenetic be-
haviours using synthetic biology principles, the eventual* Correspondence: elise.cachat@ed.ac.uk
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unless otherwise stated.aim being the self-organization of these cells into de-
signer ‘tissues’ [7,8].
The aim of synthetic morphology is greatly aided by
the observation that most normal mammalian morpho-
genesis seems to take place using about ten basic cellular
behaviours, each tissue using them in different se-
quences and to different extents [7,9,10]. Analytical ap-
proaches to developmental biology have created models
(or at least narratives) of normal development [10], but
it is difficult to test these models properly [11]. The
usual method of inactivating a key component and veri-
fying that the event fails to take place does not really test
more than the necessity for particular components (see
Davies 2009 for further discussion [12]). Synthetic biol-
ogy offers new ways of studying complex systems by the
bottom-up approach, i.e. dissecting a process into basic
events/modules and combining them back up from
scratch, building this process de novo, or at least part(s)
of it. This way, engineered cells should be able to exe-
cute simple sequences of predetermined morphogeneticLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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complex, natural setting. The approach will also allow
researchers to explore what cells can do, rather than
merely what they normally do.
Careful review of the literature indicates that many
basic morphogenetic behaviours can be triggered by the
expression of a single protein [7], making the idea of
constructing synthetic morphology modules a realistic
proposition. Here we report the construction of five
inducible effector modules, to control cell adhesion,
elective cell death, cell fusion, cell locomotion and pro-
liferation. These are produced in a standardized format,
easy to connect to existing logic and sensory modules,
and all have been made available in a public repository.
We also report the testing of these synthetic, inducible
modules in mammalian cells.
Results
Library construction
We assembled a Gateway® cloning (Invitrogen) compat-
ible pENTR library of morphogenetic effectors: these in-
clude Cdh1 (cell-adhesion [13]), Casp2 (elective cell
death [14], p14 (cell fusion [15]), Crk-II (cell locomotion
[16]) and p27Kip1 (inhibition of otherwise constitutive
proliferation [17]). The T-REx™-293 cell line (Invitrogen),
a commercially available and easy-to-maintain cell line,
was used to test these effector modules. It is derived
from Human Embryonic Kidney (HEK) cells, to which
stable expression of the tetracycline repressor protein
has been added. T-REx-293 cells were used in combin-
ation with Gateway® pT-REx™-DEST vectors, so that
driver genes could be conveniently inserted downstream
of a tetracycline-inducible promoter from our library of
pENTR library vectors. This way, effector modules could
be switched on and off using tetracycline (Tet), withoutFigure 1 The morphogenetic effectors used in this study. p27kip1 (cont
adhesion), p14 (fusion) and Crk-II (locomotion) were inserted downstream o
fluorescent reporters in pTREx destination vectors.the need for construction and testing of the elaborate
upstream logic modules that will control effector mod-
ules in advanced synthetic morphology projects [7,8,18].
After stable transfection, followed by clonal selection, in-
dependent clones were tested. Generally, effector genes
were from a non-human origin in order to facilitate
monitoring of their expression in T-REx-293 cells with
species-specific antibodies or primers, the only exception
being the gene encoding p27Kip1. Fluorescent reporters
were also used in the system, by engineering pT-REx™-
DEST vectors with IRES-TurboGFP or IRES-mCherry
cassettes downstream of the effector, or by using 2A pep-
tide fusions inside the effector cassette itself (Figure 1).
Such reporters enable (i) the testing of clones for the sim-
ultaneous expression of the reporter and the gene of inter-
est after stable selection and clonal isolation, (ii) real-time
monitoring of inducible expression and (iii) visualization
of different cell populations within a mixture of cells.
Below, we demonstrate that each driver construct’s behav-
iour is effective in controlling the expected aspect of mor-
phogenetic cell behaviour.
Effector 1: control of proliferation
By definition, mammalian cell lines proliferate constitu-
tively and indefinitely in culture [19]. In systems where
proliferation of cells needs to be controlled, chemical in-
hibitors such as mitomycin C are used. A common ex-
ample is the growth inhibition of feeder layer cells for
the expansion of stem cells [20]. However, chemical in-
hibitors can metabolically alter cells [21] and are difficult
to remove from culture systems [22]. In contrast, impos-
ing proliferation control through genetic engineering
would allow reversible, conditional and selective growth
inhibition. This way, targeted populations of cells could
selectively be controlled in systems or tissues composedrol of proliferation), Casp2 (elective cell death), Cdh1 (cell-cell
f a tetracycline-responsive promoter and coupled with different
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cell cycle is regulated by complexes of cyclins with
cyclin-dependent kinases (CDKs) [23]. Their action can
be inhibited by cyclin-dependent kinase inhibitors
(CDKIs), which are important in allowing cells to exit
the cell cycle and to differentiate during foetal develop-
ment [24]. p27Kip1 is a member of the CDKI family that
binds G1-cyclin/CDK complexes and inhibits transition
from the G1 into the S phase of the cell cycle [25]. Over-
expression of p27Kip1 causes human fibroblasts to arrest
in G1 phase [17]. To build an inducible, proliferation-
inhibiting module, we placed p27Kip1 under tetracycline
induction in the pTREx-DEST-IRES-TGFP modified
vector (pTREx-p27kip1-IRES-TGFP, Figure 1).
Control T-REx-293 cells treated with 0.05 μg/mL
tetracycline showed population growth rates similar to
untreated wild-type cells (Figure 2a,b). On the other
hand, clones stably transfected with p27Kip1 and induced
with tetracycline for 72 h showed less proliferation than
their uninduced (but still p27Kip1-carrying) counterparts
(Figure 2c). Arrested cells appeared rounded and at-
tached to the culture plate surface. It was important to
test that the great reduction in proliferation that we ob-
served was due to a reversible brake on cell cycling, and
not as a result of cell damage or cell death. To verify
this, we exploited the flexibility of the Tet induction sys-
tem and observed the behaviour of cells following re-
lease from p27Kip1-mediated inhibition of proliferation.Figure 2 Control of cell proliferation through p27kip1 inducible expre
cultured for 72 h with or without 0.05 μg/mL tetracycline. (b) Cell counts in tr
cell growth. (c) Cells from clone THGA-17 (a representative clone of T-REx-293
differences after 72 h of culture with tetracycline. (d) After 48 h of growth inh
THGA-17 cells from proliferation inhibition (green line). Scale bars: 100 μm. StaCells were induced with tetracycline for 48 h, when the
medium was replaced by the tetracycline-free version:
released cells resumed proliferation after a delay of
about one day (Figure 2d), although somewhat slower
than their never-inhibited counterparts. Arrested cells
could withstand tetracycline exposure for as long as 72 h
before resuming growth. Longer exposures resulted in
cell death.
Effector 2: elective cell death
Elective cell death (as distinct from death due to infec-
tion or external injury) is an important mechanism of
morphogenesis. It is used, amongst other things, to turn
solid rods into hollow tubes [26], to eliminate temporary
‘scaffold’ structures [27] and to balance populations of
different types of cells [28,29]. The best-understood
mechanism of elective cell death, apoptosis, is activated
by caspases: these are cysteine proteases and are classi-
fied as initiator or effector caspases, according to where
they lie in the apoptotic pathway. Caspase-2, unusually,
shows characteristics of both initiator and effector cas-
pases [30,31]. It localizes to the nucleus where it is
activated through dimerization [32]. It has been shown
to induce apoptosis when overexpressed in NIH-3T3
mouse fibroblasts [14]. To engineer an elective cell death
module, we placed mouse Casp2 under tetracycline in-
duction in the pT-REx-DEST30 vector (pTREx-Casp2,
Figure 1).ssion. (a) Control T-REx-293 cells were seeded in 6-well plates and
iplicate wells showed that tetracycline itself had no effect on wild-type
cells carrying the growth arrest module) showed clear growth rate
ibition with tetracycline, culture in tetracycline-free medium released
ndard deviation bars: n = 3.
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death module (Figure 3a, Additional file 1: Movie 1), as
well as control wild-type T-REx-293 cells treated with
tetracycline (see Figure 2a), showed little cell death and
their number increased after 48 h in culture due to pro-
liferation. After induction, the cells carrying pTREx-
Casp2 showed extensive apoptotic death, detectable by
microscopy (Figure 3a, Additional file 1: Movie 1) and
by counting the declining number of cells still adhering
to the wells (Figure 3b). To verify that the mechanism
of cell death was that intended, we used Q-VD-OPh, a
pan-caspase inhibitor. When added to the growth
medium, it largely blocked cell death after tetracycline
induction of the module (Figure 3c), confirming that the
cell death observed previously (in absence of the inhibi-
tor) was indeed caspase-driven.
Effector 3: cell-cell adhesion
Arguably, the most important regulators of cell-cell
adhesion in mammalian development are the various
cadherins, a family of calcium-dependent adhesion mol-
ecules. The first to be discovered [33,34], E-cadherin
(CDH1), is a cell surface protein involved in intercellular
adhesion of epithelial cells. This protein possesses a large
extracellular domain that consists of repeated motifsFigure 3 Tetracycline-induced cell death in Casp2-engineered T-REx-2
clone of T-REx-293 cells carrying the elective cell death module) showed n
(1 μg/mL) for 48 h. (b) Numbers of adherent, uninduced and induced THA
Standard deviation bars: n = 3. (c) When medium was supplemented with
Graph: percentages of area covered by adherent cells in various image field
tetracycline induction in the presence of Q-VD-OPh or in the presence of Qresponsible for homophilic adhesion between adjacent
cells. In the cytoplasm, its intracellular domain binds to
catenins and links E-cadherin to the actin cytoskeleton
[35]. CDH1 promotes strong cell aggregation when
expressed in mouse fibroblasts deficient in E-cadherin
(L-929 cells) [13]. To build an adhesion module, we
fused mouse Cdh1 to TurboGFP through a 2A peptide
link, and inserted the resulting cassette into pT-REx-
DEST30 (pTREx-TGFP-2A-Cdh1, Figure 1).
After clone selection, T-REx-293 cells stably trans-
fected with pTREx-TGFP-2A-Cdh1 expressed mouse E-
cadherin after 48 h of 1 μg/mL tetracycline induction, as
shown by RT-PCR analysis (Figure 4a). The primers used
to detect levels of Cdh1 mRNA were specific for mouse
Cdh1. When uninduced, cells show very little mouse E-
cadherin mRNA transcription compared to induced
cells, indicating a low level of expression leakage from
the tetracycline transcriptional switch. Wild-type cells
and T-REx-293 cells carrying the adhesion module but
without induction showed only modest cell-cell adhe-
sion: they grew in small, connected, ragged-edged
clumps that formed a network across the culture plate
(Figure 4b). Tetracycline itself had no effect on the
morphology of wild-type T-REx-293 cultures. The same
cells under tetracycline induction of Cdh1 formed much93 cells. (a) Uninduced cells from clone THAP2-2 (a representative
ormal growth, but extensive cell death when induced with tetracycline
P2-2 cells were monitored over 48 h after induction in 24-well plates.
caspase inhibitor Q-VD-OPh (50 μM), cell death was largely blocked.
s: under normal growth conditions, after tetracycline induction, after
-V-D-OPh alone. Scale bars: 100 μm.
Figure 4 Effect of the adhesion effector on engineered T-REx-293 cells. (a) Levels of murine Cdh1 mRNA expression in cells of clone THAD1-34
(a representative clone of T-REx-293 cells carrying the adhesion module), uninduced or induced with 1 μg/mL tetracycline for 48 h; and in wild-type
T-REx-293 cells treated with tetracycline, as a control, for 48 h. (b) Morphology of wild-type T-REx-293 cells and THAD1-34 cells growing
with or without tetracycline for 48 h: wild-type cells with or without tetracycline and uninduced THAD1-34 cells spread across the culture
substrate with only loose mutual association, whereas induced THAD1-34 cells adhere to one another strongly to produce dense islands
separated by clear space. Scale bars: 100 μm.
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(Figure 4b). These features are as expected, for increased
adhesion would increase ‘surface tension’ at the edges of
the islands, minimizing their circumference.
Effector 4: fusion
Cell-cell fusion is used in embryonic events such as for-
mation of skeletal muscle fibres [36]. For the purposes
of synthetic biology, it is a potentially useful way to bring
two different nuclei together in one cytoplasm, and
thus to share cytoplasmic regulators of gene expres-
sion or metabolic effectors. The fusion-associated
small transmembrane (FAST) proteins are reptilian
reovirus membrane fusion proteins that are involved
in virus dissemination in the host. They are expressed
in the plasma membrane of infected cells where they
mediate cell-cell fusion by converting pre-existing cel-
lular adhesion sites into fusion sites [37]. Apposed
membrane bilayers merge, hemifusion stalks appear,
and pores are created and expand [15]. During viralinfection, formation of the resulting extensive multi-
nucleated syncytium eventually triggers an apoptotic
response that contributes to the dissemination of in-
fection in the host [38]. p14FAST, a reptilian orthoreo-
virus protein, is known to cause cell-cell fusion when
expressed in QM5 quail fibrosarcoma cells [15], sug-
gesting it will possibly function in mammalian cells
too. To construct a fusion module, we placed p14
under tetracycline induction in the pTREx-DEST-
IRES-TGFP modified vector (pTREx-p14FAST-IRES-
TGFP, Figure 1).
Control T-REx-293 cells (see Figures 2a and 4b), and
T-REx-293 cells carrying the fusion module but without
induction (Figure 5a), showed no evidence of cell-cell
fusion. Cells overexpressing p14FAST after tetracycline
induction formed multinucleated syncytia as shown in
Figure 5a: these could be detected as large, multinucleate
cells in bright field that showed formation of tight
‘rosettes’ of nuclei visible with DAPI staining. In uninduced
(unfused) cells, cortical actin surrounds each individual
Figure 5 Tetracycline-induced cell fusion in p14-engineered T-REx-293 cells. (a) Bright-field microscopy, DAPI staining (white or magenta)
and phalloidin-FITC (green) of THFU-4 cells (a representative clone of T-REx-293 cells carrying the fusion module), treated or not with tetracycline for
24 h. Untreated cells (left column) grow normally, without obvious signs of fusion, nuclei remaining separate and surrounded individually by cell mem-
branes, shown by phalloidin stain of cortical actin filaments in the bottom row. Cells in which the fusion construct is induced show formation of large,
multinucleate cells in bright field illumination (top row), formation of ‘rosettes’ of tightly apposed nuclei (middle row), with cortical actin (green)
surrounding the whole groups of nuclei rather than each individual one (bottom row). (b) Cells grown in calcium-free medium showed fewer fusion
events, as expected (33). (c) Evidence of fusion between tetracycline-induced cells from clone THFU-10 (another representative clone) and MDCK cells
transiently expressing mCherry: unfused MDCK cells appear as small, deep red individual cells (white arrow). The red is also seen (black arrows) in large
syncytia, implying that the THFU-10 cells can fuse with cells not themselves containing the fusion module. Scale bars: 100 μm.
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surrounded by its own plasma membrane: in the induced
(fused cells), cortical actin instead surrounds complete ro-
settes of nuclei rather than individual ones, implying that
the nuclei share one common cytoplasm. Syncytia formed
through p14-induced fusion started dying around 20 h after
tetracycline induction. Fusion events were rare when cells
were grown in calcium-free medium (Figure 5b), confirm-
ing that the fusion process is calcium-dependent as ex-
pected [37]. To test whether the construct needed to be
expressed in both neighbouring cells for fusion to take
place, we mixed T-REx-293 cells carrying the fusion con-
struct with MDCK canine kidney cells that had been transi-
ently transfected with pTREx-mCherry as a marker (but
not with the fusion construct). MDCK cells were chosen as
they are well-characterized cells routinely used in our la-
boratory, and are from a different cell type and a different
species than HEK cells (dog). They do not naturally formsyncytia. In the mixed culture (Figure 5c), while some nor-
mal (unfused) MDCK cells could be seen as intensely red
individual cells, some of the large syncytia contained red
fluorescent patches suggesting that syncytia had formed in
the mixed culture, and contained cytoplasms originating
from both cell types. Potential users of this module should
note that this result implies a risk that cells carrying the fu-
sion module might fuse with cells of living humans, and po-
tentially carry dangerous genetic material such as
oncogenes and viruses into them (even basic cells lines
carry mutations making them proliferative and immortal).
Appropriate precautions should therefore be taken when
handling the cultures.
Effector 5: locomotion
Cell locomotion is a major mechanism in mammalian
development: the long migrations of the neural crest
and the primordial germ cells depend on it, as does
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the immune and inflammatory systems make constant
use of locomotion. Cell migration is driven by the local
polymerization of actin into protrusions called lamelli-
podia and filopodia, in response to a combination of in-
ternal cell state and external environmental cues [39].
These protrusions are stabilized by the formation of in-
tegrin adhesions to the extracellular matrix and extend
in the direction of migration [40,41]. Complex cytoskel-
etal reorganization also takes place at the rear of the cell,
where existing adhesions are remodelled. CRK-II, an
adaptor protein from cytoskeletal signalling pathways,
has been shown to promote cell migration when
expressed in human pancreatic carcinoma cells [16]. It
promotes the formation of lamellipodia and the loss of
cell-cell junctions (and consequent loss of cell-cell adhe-
sion) in MDCK cells [42]. To engineer a module that
promotes locomotion, we placed Crk-II under tetracyc-
line induction in the pTREx-DEST-IRES-mCherry modi-
fied vector (pTREx-CrkII-IRES-mCherry, Figure 1).
A common way of studying cell locomotion is a
scratch assay, in which a strip of cells is removed from aFigure 6 Enhanced locomotion induced by tetracycline in T-REx-293 ce
(green) during scratch closing assays showing enhanced lamellipodia formatio
locomotion module) when induced with tetracycline: the induced cells show
100 μm. (b) Distance travelled by cells in scratch closing assays with or withou
10 min and coordinates of 4 groups of cells on each side of wounds were rec
THLOII-15 cells (trail plot and graph, *p <0.001) but had no effect on wild-type
performed using a two-sample Student’s t-Test with a two-tailed distribution.monolayer and the behaviour of remaining cells can be
observed as they re-colonize the bare zone. Wild-type T-
REx-293 cells (Additional file 2: Movie 2, Additional file
3: Movie 3) and T-REx-293 cells containing the locomo-
tion module but with no induction (Additional file 4:
Movie 4), showed only modest locomotory activity; some
cells occasionally presenting a lamellipodium detectable
by phalloidin staining for actin filaments (Figure 6a).
When induced, cells expressing CRK-II exhibited en-
hanced formation of lamellipodia (Figure 6a, Additional
file 5: Movie 5), repopulated the scratched area signifi-
cantly faster and showed almost doubled motility
(Figure 6b): the motility of CRK-II-expressing cells in-
creased by a factor of 1.94, with p < 0.001 by Student’s
t-Test. Wild-type T-REx-293 cells did not show enhanced
motility in the presence of tetracycline.
Discussion
In this study, we describe a synthetic library of five
separate morphogenetic effector modules that induce
five morphological behaviours in T-REx-293 cells. We
have made these biological parts available to others bylls engineered with Crk-II. (a) DAPI staining (blue) and phalloidin-FITC
n in THLOII-15 cells (a representative clone of T-REx-293 cells carrying the
more frequent formation of lamellipodia, shown in green. Scale bars:
t induction of the locomotion module. Images were acquired every
orded (6 to 18 h post-induction). Tetracycline increased the migration of
cells (graph). Statistical analysis was
Standard deviation bars: n = 8.
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pENTR vectors. We have chosen the T-REx-293 cell line
as our engineering chassis for its ease of transfection
and its built-in tetracycline transcriptional control. It
would be interesting to find out how easily our tools can
be engineered in cell types that are more problematic to
transfect or where sustained transgene expression is dif-
ficult to achieve. It would also be useful to know how re-
liably our effectors perform in other cell lines. The
constructs assembled here do not contain cell-type-
specific features and should therefore be functional in
other mammalian cells. Importantly, the cytomegalo-
virus (CMV) promoter (used in the T-REx system) has
been reported to show poor activity in some cell lines
[43] and promoters such as elongation factor 1α (EF1α)
could improve transgene expression if needed [44]. This
might be particularly relevant when engineering stem
cell chassis where CMV has been shown to have poor
transcriptional activity [45]. The resultant stem cells (i.e.
stably transfected with functional and inducible morpho-
genetic effectors) could offer new options for synthetic
approaches to tissue-engineering.
Also, we have used a simple controlling switch in this
study to demonstrate the basic functions of the modules
in a synthetic biology context. Better performance may
come from more sophisticated switches, for example of
the type described by Deans et al. [46], that combine
RNAi and repressor proteins to improve the leakiness
associated with the tetracycline switch. Using switches
with translational or post-translational control might
also change the kinetics of the system and confer a faster
response to environmental cues. In addition, using dif-
ferent promoters may allow for better tunability over the
desired morphologic changes in engineered mammalian
cells. Also, IRES-dependent expression of fluorescent
markers was extremely variable, when expression from
2A constructs was robust and reliable. Exploring the use
of other IRESes than the encephalomyocarditis virus
(EMCV) IRES used in this study might help to get reli-
able fluorescent marker expression from bicistronic vec-
tors [47].
We are currently combining sequences of morpho-
genetic effectors in a series of proof-of-concept trials for
synthetic morphology, where cells are genetically pro-
grammed to organize themselves into designed 2D or
3D structures in response to artificial external stimuli.
To this end, several morphogenetic effectors can be
combined in the same chassis, with each effector placed
under the control of a different switch to ensure they
can be induced at different times or rates.
Conclusions
There are two broad fields in which the modules de-
scribed here (and others like them) may be useful,particularly if placed under the control of existing sens-
ing and logic modules [48,49]. The first is the testing of
fundamental theories of developmental biology. There is
a strong thread of philosophical thought, traceable to
Giambattista Vico (1668-1744), that we can be sure we
understand something only if we can (re)create it: syn-
thetic biologists often quote Richard Feynmann’s re-
statement of this principle as ‘what I cannot create, I do
not understand’. Analytical biology has produced models
of how morphogenesis works in simple tissues: using
synthetic morphological modules to try to teach naïve
cells to undergo similar morphogenesis is a powerful
mean of testing the quality of these modules [7]. The
second field in which these modules may be useful is
that of tissue engineering, especially adapting human
cells to live in culture, whether for life-support ma-
chines or as test beds for pharmaceutical efficacy or
toxicity screening [50-52]. Combinations of various cell
lines with different morphologic effectors (the ones
described here and others yet unpublished) could be
assembled. Importantly, the resulting cell arrangements
would not be restricted to natural ones and un-natural,
designed structures could be obtained and may, in the
future, be used in surgery and regenerative medicine,




Mouse Cdh1 was amplified from plasmid pBATEM2
[BCCM/LMBP #3585] [53]; mouse Casp2 was amplified
from plasmid pCMF2E-mCASP-2 [BCCM/LMBP #4588]
[54], reptilian orthoreovirus p14 [GenBank: AY238887]
was custom-synthesised (Integrated DNA Technologies),
Crk-II was amplified from adult mouse kidney cDNA and
human p27kip1 was amplified from plasmid pcDNA3.1_p27
kindly provided by Bruno Amati [55]. Effector genes were
PCR amplified with primers containing attachment
(att) sites for Gateway® recombination according to
manufacturer’s instructions and recombined by BP re-
action in vector pDONR-221 kindly donated by Agnès
Roure [56]. The resulting pENTR vectors were deposited
to the Addgene plasmid repository. Effector genes were
inserted into pT-REx-DEST30 (Invitrogen), pTREx-DEST-
IRES-TGFP or pTREx-DEST-IRES-mCherry vectors by
LR reaction according to manufacturer’s instructions.
pTREx-DEST-IRES-TGFP and pTREx-DEST-IRES-mCherry
vectors were generated by inserting NheI/MfeI IRES-
TurboGFP or IRES-mCherry cassettes in pT-REx-
DEST30. The TurboGFP and mCherry genes were
cloned from pTurboGFP-N (Evrogen) and pCherryPicker2
(Clontech), respectively. Plasmid pTREx-mCherry was
created by inserting the mCherry gene into pT-REx-
DEST30.
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T-REx-293 cells (Invitrogen) were maintained in T-REx-
293 culture medium, which consisted of DMEM (Gibco
41966) supplemented with 10% fetal bovine serum (FBS,
Biosera) and 5 mg/mL blasticidin (Gibco), at 37°C and
5% CO2. MDCK cells were maintained in MEM medium
(Sigma) supplemented with 5% FBS and 1% Penicillin/
Streptomycin/L-Glutamine (Sigma). T-REx-293 cells
were transfected in 24-well plates using 1 μg effector
plasmids and 2 μL lipofectamine 2000 (Invitrogen), in
100 μL Opti-MEM (Gibco) for each well. Cells were
then selected using 800 mg/mL G418 (Sigma) for
2 weeks. Stably transfected cells were maintained and
tested in T-REx-293 culture medium with 200 mg/
mL G418. Individual clones were isolated by plating sta-
bly transfected cells in 10-cm cell culture dishes (Corn-
ing) at a density of 300-500 cells/dish and cultured for
7-10 days (until individual colonies reached over 100
cells in size). Colonies were picked using cloning cylin-
ders (Bellco) and expanded. For adhesion clones, 1 μg/
mL tetracycline (Sigma) was added prior to selection
and only GFP-positive colonies were picked. After clonal
selection and expansion, all clones were tested for their
response to tetracycline induction (1 μg/mL tetracycline
for 24 to 48 h). For the adhesion and locomotion mod-
ules, clones were selected according to their GFP/
mCherry fluorescence intensity and homogeneity (clones
THAD1-34 and THLOII-15 were chosen for further as-
says). For the elective cell death and fusion modules,
clones were selected according to the level of cell death
or fusion observed (clones THAP2-2, and THFU-4, -9
and -10). For the proliferation control module, clones
were selected according to their GFP fluorescence inten-
sity and growth rate (clones THGA-6 and -17). When
testing the elective cell death module, the caspase inhibi-
tor Q-VD-OPh (Sigma) was added to the medium
(50 μM). The fusion module was tested in regular T-
REx-293 culture medium or in calcium-free medium
(Gibco 21068) supplemented with 2 mM L-glutamine
(Gibco 25030), 10% FBS and 5 mg/mL blasticidin.
Cell imaging
Live cell images were acquired using a Zeiss AxioObser-
ver D1 inverted fluorescence microscope with AxioCam
MRm and a 10× objective. Filter excitation (EX) and
emission (EM) bandpass specifications were as follows
(in nm): GFP (EX: 470/40, EM: 525/50); mCherry (EX:
545/25, EM: 605/70). Immunostaining images were ac-
quired using the previous Zeiss AxioObserver or the
Zeiss AxioImager A1 upright fluorescence microscope
with AxioCam MRm and 10x or 20x objectives. Filter
excitation (EX) and emission (EM) bandpass specifica-
tions were as follows (in nm): DAPI (EX: 365, EM: 445/
50); FITC (EX: 450/90, EM: 515/65). For phalloidinimmunostaining, cells were seeded on sterile coverslips
or in culture plates directly and treated with 1 μg/mL
tetracycline for 24 h before fixation with 4% paraformal-
dehyde. After fixation, cells were permeabilized with
0.1% Triton X-100 and incubated with 0.1 μg/mL
FITC-conjugated phalloidin (Sigma) for 1 h at room
temperature. Next, cells were stained with 300 nM 4′,6-
Diamidino-2-Phenylindole (DAPI) and mounted on glass
slides with Vectashield Hardset mounting media (Vec-
tor) for fluorescence microscope imaging, when not im-
aged directly in wells.
Scratch closing assay
Cells were seeded in 2 mL medium in duplicated 6-well
plates. At 90% confluence, cells were scratched and
1 μg/mL tetracycline was added. Time-lapse recordings
were performed on LumaScopes 500 (Etaluma, Inc.
Carlsbad, CA) with 20x objectives at 37°C and 5% CO2.
Induced and uninduced wells were imaged in parallel
every 10 min for 24 h. Images were captured in the na-
tive LumaView software, and ImageJ was used to follow
the distance travelled by cells. Four small groups of cells
on each side of the scratch were marked image per
image, and their coordinates used to calculate the dis-
tance travelled between 6 to 18 h after induction. Statis-
tical analysis was performed using a two-sample
Student’s t-Test with a two-tailed distribution. Multiple
scratch closing assays were conducted showing similar
results; representative single assays (n = 8) were chosen
to illustrate these results in Figure 6b.
Cell counts
To test the proliferation control module, cells were
seeded in 6-well plates and induced with 0.05 μg/mL
tetracycline for 48 h before replacing the growth
medium with tetracycline-free medium. Adherent cell
numbers were determined at different times after induction
and after release from induction: at each time point, cells
from triplicate wells were harvested by trypsinization after
removal of growth medium (containing negligible numbers
of floating dead cells), and cells were counted on haemocy-
tometers. To test the elective cell death module, cells were
seeded in 24-well plates and induced with 1 μg/mL tetra-
cycline. Adherent cell numbers were determined at differ-
ent times before and after induction as described above. To
quantify the effect of the Q-VD-OPh caspase inhibitor on
induced cell death, images of cell culture 48 h after induc-
tion were analysed on ImageJ: cell numbers were estimated
by measuring the area covered by remaining adherent cells
in duplicate image fields.
RT-PCR
mRNA was extracted from wild-type T-REx-293 cells
and from clone THAD1-34 cells induced or uninduced
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confluence from a 6-well plate and mRNA was extracted
following RNeasy kit’s instructions (QIAGEN) with an
additional DNA digestion step with DNase (QIAGEN).
RT-PCR was performed on 2 μg of RNA with MLV-RT
(Promega). cDNAs from Cdh1 and β-actin as internal
control were amplified with specific primers over 20
PCR cycles. Primers for mouse Cdh1: Cdh1_129F (TGC
CGGAGAGGCACCTGGAG) and Cdh1_391R (GGTG
GTGGTGCCGGTGATGG); primers for β-actin: β-
actin_F (CTGGGACGACATGGAGAARA) and β-actin_R
(AAGGAAGGCTGGAARAGWGC)].Additional files
Additional file 1: Movie 1. Time-lapse imaging of cells from clone
THAP2-2 undergoing tetracycline-induced elective cell death (images
captured every 30 min for 70 h after addition of Tet).
Additional file 2: Movie 2. Time-lapse imaging of wild-type T-REx-293
cells in control scratch closing assay without tetracycline (images captured
every 10 min for 12 h).
Additional file 3: Movie 3. Time-lapse imaging of wild-type T-REx-293
cells in scratch closing assay with 1 μg/mL tetracycline (images captured
every 10 min for 12 h: 6 to 18 h after addition of Tet).
Additional file 4: Movie 4. Time-lapse imaging of cells from clone
THLOII-15 in control scratch closing assay without tetracycline (images
captured every 10 min for 12 h).
Additional file 5: Movie 5. Time-lapse imaging of cells from clone
THLOII-15 in scratch closing assay with 1 μg/mL tetracycline (images
captured every 10 min for 12 h: 6 to 18 h after addition of Tet). Notes:
All movies have the same spatial scale (1 mm across) and run at the
same speed for ease of comparison, except for Movie 1 which runs three
times faster.Abbreviations
2D: Two-dimensional; 3D: Three-dimensional; GFP: Green fluorescent protein;
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